• David E Zimmerman, Benjamin Johnson, Amanda Kearns, Heather Metro, Abigail Robb, Branden D Nemecek, Courtney A Montepara, Jordan R Covvey, and Michael J Lynch.
• Duquesne University School of Pharmacy, Pittsburgh, PA, USA; University of Pittsburgh Medical Center - Mercy Hospital, 600 Forbes Ave, Pittsburgh, PA, USA. Electronic address: zimmerm6@duq.edu.
• Am J Emerg Med. 2024 Mar 1; 77: 154157154-157.

ObjectiveBuprenorphine is an effective treatment for opioid use disorder (OUD). Patients in the emergency department (ED) can be initiated or continued on buprenorphine as a bridge to follow-up in the outpatient setting, but gaps in care may arise. The objective was to evaluate the impact of buprenorphine to-go packs as a continuing treatment option for patients presenting to the ED with OUD across a health system.MethodsAdult patients discharged with a buprenorphine to-go pack from one of ten EDs within a major health system were included. The primary outcomes assessed within 30 days of ED discharge were: (1) return to a health system ED, and (2) fill history of buprenorphine in the state prescription drug monitoring program database. Data was analyzed using descriptive statistics in Microsoft Excel (Redmond, WA).ResultsA total of 124 patients received buprenorphine to-go packs. The sample was primarily male (79; 63.7%), white (89; 71.8%), on Medicaid (79; 63.7%), and had a mean age of 40.9 years. A total of 43 patients (34.7%) were initiated on buprenorphine for the first time, while 81 (65.3%) had received buprenorphine (prescription or to-go) previously. At 30 days post-visit, 76 (61.3%) had filled buprenorphine prescriptions, and 40 (32.3%) returned to an ED within the health system for opioid withdrawal (17; 42.5%), non-OUD-related reasons (22; 55%), or overdose (1; 2.5%).ConclusionThe implementation of a system-wide buprenorphine to-go supply at ED discharge is a feasible option to provide continuity of care to patients with OUD.Copyright © 2023 Elsevier Inc. All rights reserved.

15 keywords...

hide…